During AACR 2016, Nicolai Wagtmann, Chief Scientific Officer of Innate Pharma, held a conference call to the attention of analysts and portfolio managers to discuss the data published and Company’s innovative pipeline.
Innate in the news
La biotech marseillaise a dévoilé aux investisseurs des données précliniques sur quelques-uns de ses actifs les plus prometteurs. De quoi nourrir l’optimisme sur l'avenir d'Innate Pharma.
Innate Pharma is deeply saddened to learn the death of Holbrook Kohrt, brilliant immunologist and most respected oncology physician. His innovative cancer immunotherapy work at Stanford University School of Medicine led directly to the development of clinical trials that may transform the care of cancer patients.
Holbrook has been a long time academic collaborator of Innate Pharma and contributed greatly to most of our research and clinical programs. Many in our teams have had the privilege to work with him on translational research and have benefited from his scientific and medical insights as well as from his enthusiasm and passion for bringing new therapeutic options to patients.
We will all miss Holbrook and our thoughts go to his family, loved ones, colleagues and patients.